Nivolumab and Ipilimumab +/- UV1 Vaccination as 2nd Line Treatment in Patients with Malignant Mesothelioma (the NIPU-Study)

V. Haakensen, A. Nowak, E. Ellingsen, O. Grundberg, S. Farooqi, T. Mcculloch, S. Cedres, M. Bjaanæs, Å. Helland

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberP24.07
JournalJournal of Thoracic Oncology
Volume16
Issue number3, Suppl.
Pages (from-to)S380
ISSN1556-0864
DOIs
Publication statusPublished - 2021
Event2020 World Conference on Lung Cancer - Virtual Meeting
Duration: 28 Jan 202131 Jan 2021

Conference

Conference2020 World Conference on Lung Cancer
LocationVirtual Meeting
Period28/01/202131/01/2021

Cite this